389
Views
3
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP

, , , , , , & show all
Pages 730-740 | Received 30 Mar 2021, Accepted 20 Dec 2021, Published online: 13 Feb 2022
 

Statement of Retraction

We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

Feng Yu, Ying Lin, Guojie Tan, Maomao Ai, Huicheng Gong, Wei Liu, Jiali Huang and Zirou Zou. Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP. Cell Cycle. 2020;21(7):730-740. doi: 10.1080/15384101.2021.2022845

Since publication, significant concerns have been raised about the integrity of the data and reported results in the article. When approached for an explanation, the authors did not provide their original data or any necessary supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. The authors agree/do not agree with the retraction.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:
Statement of Retraction: Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.